EDIT vs OMC · rev $32.3M vs rev $17.27B
Editas Medicine Inc (EDIT) versus Omnicom Group Inc (OMC) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Omnicom Group Inc (OMC) is a advertising agencies company listed on NYSE.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported OMC revenue for 2025-12-31 was $17.27B. Net income was -$54.5M. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. OMC currently screens at market cap $21.75B.
EDIT currently screens at market cap $375.2M. OMC currently screens at market cap $21.75B.
Not investment advice. Open the EDIT and OMC stock pages for the full models.
Not investment advice.